Longitudinal Analysis of Serum Copper and Ceruloplasmin in Alzheimer's Disease
Alan Rembach, James D Doecke, Blaine R Roberts, Andrew D Watt, Noel G Faux, Irene Volitakis, Kelly K Pertile, Rebecca L Rumble, Brett O Trounson, Christopher J Fowler, William Wilson, Kathryn A Ellis, Ralph N Martins, Christopher C Rowe, Victor L Villemagne, David Ames, Colin L Masters, Ashley I Bush
JOURNAL OF ALZHEIMERS DISEASE | IOS PRESS | Published : 2013
Related Projects (1)
Core funding for the study was provided by CSIRO, which was supplemented by "in kind" contributions from the study partners (see http://aibl.csiro.au/). The research was also supported by the Science Industry and Endowment Fund (see http://sief.org.au/), and the National Health and Medical Research Council (NHMRC) via the Dementia Collaborative Research Centres program (DCRC2). MHRI acknowledges funding support from the Victorian Government's Operational Infrastructure Support program. Pfizer International has contributed financial support to assist with analysis of blood samples and to further the AIBL research program. The McCusker Foundation has contributed financial and in-kind support to AIBL. Dr. Faux was supported by a National Health and Medical Research Council (NHMRC) training fellowship. Dr. Rembach was supported by the CSIRO Office of the Chief Executive (OCE) postdoctoral fellowship and the JO & JR Wicking Trust and the Mason Foundation facilitated through ANZ trustees.